Global Network
One partner to keep your molecule moving at pace by uniting R&D and Operations to navigate accelerated pathways.
World #1 API network with downstream integration
Hovione combines a global API network with an integrated R&D ecosystem to support your Drug Substance project from early development through commercial manufacturing—guided by rigorous safety standards and regulatory compliance.
Our Global R&D team delivers end-to-end API process development, from chemistry and analytical development to safety, scale-up, and regulatory support. Using data-rich experimentation, Process Analytical Technology, and advanced modelling tools, we enable efficient scale-up and continuous process optimization.
Our development expertise is seamlessly connected to our global API manufacturing capabilities and network, ensuring reliable technology transfer and a predictable path to commercial production. With sites across Europe, North America, and Asia, we deliver global supply chain security, operational continuity, and scalable production capacity—from kilograms to tons—to support your product throughout its lifecycle.
Backed by more than 40 FDA inspections over four decades, our regulatory track record reinforces this global reliability, giving you confidence around every audit, submission, and milestone.
Downstream Integration: Particle Engineering and Drug Product
Beyond Drug Substance development and manufacturing, Hovione provides downstream integration through Particle Engineering technologies—including our industry-leading Amorphous Solid Dispersion by Spray Drying platform, Drug Product development, and manufacturing solutions. This integrated CDMO model helps optimize molecule performance, bioavailability, and manufacturability while maintaining alignment across development, scale-up, and commercial supply.
Contact us to learn how our integrated Drug Substance solutions can support your project.